Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06935513

Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations

The purpose of this study is to evaluate the control effect of smart wearable devices on key risk factors in the high-risk populations for stroke

Recruiting

Interested in participating?

Request Info

Key information

About this study

A randomized controlled study was conducted on the application of smart wearable devices in the intervention of high-risk populations for stroke, with a focus on whether the functions of smart wearable devices such as medication reminders, heart rate monitoring, and exercise reminders can effectively benefit the improvement of key risk factors for stroke, especially blood pressure, blood glucose, and blood lipids.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed with hypertension;
  • Diagnosed with diabetes;
  • Diagnosed with atrial fibrillation;
  • Smoking subjects;
  • Physical inactive subjects;
  • Obesity and overweight subjects;
  • Must be able to use smart wearable devices.

Exclusion criteria

  • Diagnosed with malignancies;
  • Diagnosed with psychiatric disorders;
  • Diagnosed with cognitive impairment;
  • Unable to operate smart wearable devices.

Treatment and study plan

Wearable Devices

Behavioral

Participants utilize wearable devices (smart wristbands) 24 hours a day for 6 months. Wearable devices can provide medication reminders for each use and heart rate monitoring.

Primary outcomes

  1. medication adherence and risk factor control rates

    Time frame: 6 months

    1.The medication rates and control rates for hypertension; 2.The medication rates and control rates for hyperglycemia; 3. The medication rates and control rates for hyperlipidemia; 4.The medication rates and control rates for obesity.

Secondary outcomes

  1. incident vascular events, including stroke, coronary heart disease (CHD), peripheral vascular disease (PVD), and other related cardiovascular events

    Time frame: 6 months

    Stroke is a sudden interruption of blood flow to the brain, caused by either a blockage (ischemic stroke) or rupture of a blood vessel (hemorrhagic stroke). Coronary heart disease is a cardiovascular condition characterized by the narrowing or blockage of the coronary arteries, the blood vessels that supply oxygen-rich blood to the heart muscle. Peripheral vascular diseases are circulatory disorders characterized by narrowing, blockage, or spasms in blood vessels outside the heart and brain, most commonly affecting arteries supplying the legs, arms, kidneys, or stomach.

Study contacts

Contact information is provided by the study sponsor or research team.

Pengyu Gong, MD

CONTACT

[email protected]

+8615720800870

Qiuhong Ji, MD, PhD

CONTACT

[email protected]

+8613962916293

Sponsors and collaborators

Lead sponsor

Affiliated Hospital of Nantong University

Other

Registry information

Acronym: AISP

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Apr 20, 2025
Registry last updated
Apr 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.